News Medical on MSN
Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific ...
ArgenTag joins PacBio to enable instrument-free single-cell kits to support long-read isoform sequencing at single-cell resolution.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results